CCL21 and neoplasm: In vivo studies show the knockdown of CCL21 in secondary lymphoid organs leads to the decrease of metastatic tumor formation, since this reduces both the chemotactic and antiapoptotic effects of CCR7-expressing tumor cells (Wang et al., 2008).